Lalit Kumar

10.3k total citations · 1 hit paper
432 papers, 6.8k citations indexed

About

Lalit Kumar is a scholar working on Molecular Biology, Oncology and Pharmaceutical Science. According to data from OpenAlex, Lalit Kumar has authored 432 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Molecular Biology, 62 papers in Oncology and 61 papers in Pharmaceutical Science. Recurrent topics in Lalit Kumar's work include Lymphoma Diagnosis and Treatment (44 papers), Advanced Drug Delivery Systems (36 papers) and Analytical Methods in Pharmaceuticals (32 papers). Lalit Kumar is often cited by papers focused on Lymphoma Diagnosis and Treatment (44 papers), Advanced Drug Delivery Systems (36 papers) and Analytical Methods in Pharmaceuticals (32 papers). Lalit Kumar collaborates with scholars based in India, United States and Australia. Lalit Kumar's co-authors include Ruchi Verma, Shubhrata Gupta, Shivam Prakash Gautam, Rupesh Kalidas Shirodkar, Shamsuzzama Shamsuzzama, Salwa, Aamir Nazir, Rizwanul Haque, Atul Sharma and Roopa Hariprasad and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Physical Review Letters and The Journal of Experimental Medicine.

In The Last Decade

Lalit Kumar

393 papers receiving 6.6k citations

Hit Papers

3D Printing as a Promising Tool in Personalized Medicine 2021 2026 2022 2024 2021 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lalit Kumar India 42 1.7k 803 727 685 598 432 6.8k
Tae Hee Kim South Korea 41 2.1k 1.2× 352 0.4× 350 0.5× 219 0.3× 1.1k 1.8× 264 6.3k
Lei Nie China 44 2.3k 1.4× 311 0.4× 375 0.5× 435 0.6× 2.2k 3.6× 278 7.5k
Giovanni Traverso United States 47 3.5k 2.1× 1.0k 1.3× 1.5k 2.1× 1.1k 1.6× 3.0k 5.1× 170 11.4k
Yan Li China 49 2.6k 1.5× 210 0.3× 381 0.5× 708 1.0× 1.6k 2.7× 276 7.7k
Yan Wang China 52 3.4k 2.0× 544 0.7× 2.9k 4.0× 1.2k 1.7× 665 1.1× 672 12.2k
Min Li China 42 2.8k 1.6× 160 0.2× 525 0.7× 545 0.8× 746 1.2× 473 8.1k
Jeong Hun Kim South Korea 56 4.2k 2.5× 264 0.3× 663 0.9× 533 0.8× 1.2k 2.1× 412 11.0k
Shuang Zhao China 41 2.1k 1.2× 218 0.3× 1.3k 1.8× 765 1.1× 838 1.4× 474 7.7k
Man Li China 56 3.8k 2.2× 756 0.9× 1.9k 2.6× 1.0k 1.5× 2.2k 3.6× 354 9.8k
Ju Zhang China 46 2.9k 1.7× 139 0.2× 620 0.9× 987 1.4× 716 1.2× 369 7.7k

Countries citing papers authored by Lalit Kumar

Since Specialization
Citations

This map shows the geographic impact of Lalit Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lalit Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lalit Kumar more than expected).

Fields of papers citing papers by Lalit Kumar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lalit Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lalit Kumar. The network helps show where Lalit Kumar may publish in the future.

Co-authorship network of co-authors of Lalit Kumar

This figure shows the co-authorship network connecting the top 25 collaborators of Lalit Kumar. A scholar is included among the top collaborators of Lalit Kumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lalit Kumar. Lalit Kumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Sharma, Daya Nand, Rajesh Khadgawat, Lalit Kumar, et al.. (2025). The serum levels of leptin and adiponectin in endometrial carcinoma and their association with histopathological factors. Journal of Cancer Research and Therapeutics. 21(1). 98–103.
3.
Kumar, Lalit, et al.. (2024). Investigation into ZSM-48 framework acidity for maximization of p-xylene in toluene methylation. Molecular Catalysis. 554. 113816–113816. 7 indexed citations
4.
Verma, Ashish, Priyamvada Gupta, Harshita Tiwari, et al.. (2024). Urinary miRNAs in bladder cancer. Clinica Chimica Acta. 567. 120113–120113. 3 indexed citations
5.
Kumar, Lalit, et al.. (2024). Highly selective hydrodeoxygenation catalyst for sustainable aviation fuel production from used cooking oil. Catalysis Today. 442. 114895–114895. 8 indexed citations
6.
Birangal, Sumit, et al.. (2024). An in-silico approach for the identification of natural compounds as potential BACE1 inhibitors for the treatment of Alzheimer disease. Journal of Applied Pharmaceutical Science. 292–304. 1 indexed citations
7.
Bhaskaran, Navya Ajitkumar, Srinivas Reddy Jitta, Salwa, et al.. (2023). Folic acid-chitosan functionalized polymeric nanocarriers to treat colon cancer. International Journal of Biological Macromolecules. 253(Pt 5). 127142–127142. 22 indexed citations
9.
Kumar, Lalit, et al.. (2023). Oral Gastroretentive Film of Lacidipine for the Treatment of Gastroparesis. Assay and Drug Development Technologies. 21(3). 97–109. 3 indexed citations
10.
Kumar, Lalit, et al.. (2023). Formulation and Characterization of Nanoparticulate Drug Carrier System for Lacidipine. Assay and Drug Development Technologies. 21(7). 309–324. 3 indexed citations
11.
Kumar, Lalit, et al.. (2023). Poly(lactic-co-glycolic) Acid (PLGA) Nanoparticles and Transdermal Drug Delivery:An Overview. Current Pharmaceutical Design. 29(37). 2940–2953. 10 indexed citations
12.
Kumar, Lalit, et al.. (2023). Application of nano size ZSM-48 zeolite framework for toluene methylation to p-xylene. Molecular Catalysis. 547. 113269–113269. 6 indexed citations
13.
Kumar, Lalit, et al.. (2023). 3D printing in personalized medicines: A focus on applications of the technology. Materials Today Communications. 35. 105875–105875. 50 indexed citations
15.
Kumar, Lalit, et al.. (2022). Solubility Enhancement of Ebastine by Formulating Microemulsion Using D-Optimal Mixture Design: Optimization and Characterization. Assay and Drug Development Technologies. 20(6). 258–273. 5 indexed citations
16.
Jitta, Srinivas Reddy, et al.. (2021). Development and Validation of High-Performance Liquid Chromatography Method for the Quantification of Remdesivir in Intravenous Dosage Form. Assay and Drug Development Technologies. 19(8). 475–483. 12 indexed citations
17.
Gourishetti, Karthik, et al.. (2020). Sesamol-Loaded PLGA Nanosuspension for Accelerating Wound Healing in Diabetic Foot Ulcer in Rats. SHILAP Revista de lepidopterología. 1 indexed citations
18.
Gopalakrishnan, Tharani, et al.. (2020). Assessment of Spatial and Temporal Trend of Groundwater Salinity in Jaffna Peninsula and Its Link to Paddy Land Abandonment. Sustainability. 12(9). 3681–3681. 18 indexed citations
19.
Ghosh, D., Lalit Kumar, Tapas Kumar Mandal, et al.. (2019). A revisit to the effect of annealing temperature on magnetic properties of LaFe 0.5 Mn 0.5 O 3. Journal of Physics Condensed Matter. 31(22). 225801–225801. 5 indexed citations
20.
Gautam, Shivam Prakash, et al.. (2018). Single and multi switch fault tolerant topology of multi level inverter. 1–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026